Novo, Kallyope link to develop obesity, diabetes therapies
admin 20th June 2018 Uncategorised 0Novo Nordisk and Kallyope are joining forces to discover novel peptide therapeutics for obesity and diabetes.
More: Novo, Kallyope link to develop obesity, diabetes therapies
Source: News